EDMONTON, Alta.--Bioinformatics software provider BioTools recently announced that it has entered into a strategic partnership with Tokyo-based Sawady Technology to promote, market, and sell BioTools's custom peptide synthesis services to customers in Japan and Asia under a nonexclusive license. The partnership is worth approximately $500,000 in annual peptide synthesis revenues to BioTools, the company stated.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.